AKT1 and gastric cancer: Regarding the growth-related signaling pathways operating in HER2-positive gastric cancer, the dysregulation of PI3K/AKT signaling pathways is frequently involved in the mechanism of resistance to trastuzumab [8]; and increased activity of MAPK/ERK signaling pathways results in invasion and metastasis in GC [9].